Stock Updates

Is this Large Market Cap Stock target price reasonable for Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

The company in question is, Integra LifeSciences Holdings Corporation (NASDAQ:IART) currently with a stock price of 81.25 (0.38% today). The market cap for Integra LifeSciences Holdings Corporation is 2985.07, and is in the sector Healthcare, and Medical Instruments & Supplies industry. The target price for Integra LifeSciences Holdings Corporation is 90.5. Currently Integra LifeSciences Holdings Corporation is trading with a P/E of 525.58, and a forward P/E of 20.49. Average volume for Integra LifeSciences Holdings Corporation is 291.58 and so far today it is 76740.

Performance in the last year for Integra LifeSciences Holdings Corporation has been 40.40%. For EPS growth, Integra LifeSciences Holdings Corporation has seen a growth of -82.00%, and is looking to grow in the next year to 13.57%. More long term stats show that EPS growth has been -38.10% over the last five years and could be 12.15% for the next five years. Integra LifeSciences Holdings Corporation has seen sales growth quarter over quarter at 17.20%, with EPS growth quarter over quarter at -8.50%. The 20-day simple moving average is -4.35%, with the 200-day simple moving average coming to 10.96%.

Since the IPO date for Integra LifeSciences Holdings Corporation on the 8/16/1995, Integra LifeSciences Holdings Corporation has seen performance year to date to be 19.42%. With Integra LifeSciences Holdings Corporation trading at 81.25, the dividend yield is *TBA, and the EPS is 0.15.

So could Integra LifeSciences Holdings Corporation, be undervalued? Well as said before P/E is 525.58. The PEG is 43.26, P/S is 3.13 and the P/B is at 3.79. The P/cash is 34.39, with P/free cash flow at 91.57.

Integra LifeSciences Holdings Corporation ability to deal with debt shows that the current ratio is 3.3, and the quick ratio is 1.8. This is with long term debt/equity at 0.86, and total debt/equity at 0.89.

In terms of margins, Integra LifeSciences Holdings Corporation has a gross margin of 63.30%, an operating margin of 8.20% and a profit margin of 1.00%.Payout ratio for Integra LifeSciences Holdings Corporation is 0.00%. Return on assets come to 0.50% with return on investment coming to 1.90%.

Insider ownership for Integra LifeSciences Holdings Corporation, is at 3.40% and institutional ownership comes to 90.10%. Outstanding shares are at 36.88. While shares float is 30.04. The float short is currently 8.22%, and short ratio is 8.47.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment